Vaccinium emarginatum
Vaccinium emarginatum · Accepted scientific name
Scientific literature: Very Sparse (13 studies) · ★☆☆☆☆
, scientifically known as Vaccinium emarginatum, is a resilient shrub native to high-altitude regions. Belonging to the Ericaceae family, this plant produces nutrient-rich berries valued for their antioxidant properties. Often studied for its potential therapeutic benefits, it offers a fascinating subject for ethnobotanical research and natural medicinal exploration.
- Family
- Ericaceae
- Native range
- Asia-Temperate
- Parts used
- Root
- Common names
- Not available
- Scientific synonyms
- Agapetes Emarginata · Vaccinium Amamianum
Names
Scientific Names
Accepted name
Vaccinium emarginatumSynonyms
- Agapetes emarginata
- Vaccinium amamianum
Taxonomical Classification
This plant belongs to the kingdom Plantae and is classified under the phylum Streptophyta and the class Equisetopsida. Within the subclass Magnoliidae, it is part of the order Ericales and falls under the family Ericaceae. Finally, it is specifically categorized under the genus Vaccinium.
| Rank | Classification | Source |
|---|---|---|
| Kingdom | Plantae | WCVP |
| Phylum | Streptophyta | WCVP |
| Class | Equisetopsida | WCVP |
| Subclass | Magnoliidae | WCVP |
| Order | Ericales | WCVP |
| Family | Ericaceae | WCVP |
| Genus | Vaccinium | WCVP |
Distribution
This plant exhibits a specific geographical range concentrated within the regions of Eastern Asia. Its natural habitat includes the Nansei-shotō islands, which are part of the Ryukyu archipelago. Furthermore, the species can be found growing within the subtropical landscapes of Taiwan. This distribution pattern highlights its preference for these particular island and coastal environments. Consequently, its presence is limited to these distinct East Asian locations.
| Region | Area | Source |
|---|---|---|
| Eastern Asia | Nansei-shoto | WCVP |
| Eastern Asia | Taiwan | WCVP |
Plant Parts
This plant, Vaccinium emarginatum, belongs to the Ericaceae family, and like many of its relatives in the genus Vaccinium, it maintains a specialized relationship with soil microorganisms. While the plant possesses various structural components such as stems, leaves, and berries, one of its most biologically significant features is the presence of the root nodule. These specialized structures form on the roots through a symbiotic association with ericoid mycorrhizal fungi, which play a critical role in assisting the plant with nutrient uptake in nutrient-poor environments.| Plant Part | Sources | Consensus |
|---|---|---|
| root | Pharmaceuticals (Basel, Switzerland) (and other 1 sources) | ★☆☆☆☆ |
Chemicals
Vaccinium emarginatum has 10 reported phytochemicals identified across 1 scientific publications and several other databases. The most consistently reported chemicals include CATECHIN, Epicatechin, Hyperin, Isoquercetin, Lupeol.
| Chemical | Supporting sources | Consensus |
|---|---|---|
| CATECHIN | 1 supporting sources | ★☆☆☆☆ |
| Epicatechin | 1 supporting sources | ★☆☆☆☆ |
| Hyperin | 1 supporting sources | ★☆☆☆☆ |
| Isoquercetin | 1 supporting sources | ★☆☆☆☆ |
| Lupeol | 1 supporting sources | ★☆☆☆☆ |
| Procyanidin A1 | 1 supporting sources | ★☆☆☆☆ |
| Procyanidin B3 | 1 supporting sources | ★☆☆☆☆ |
| alpha-Amyrin | 1 supporting sources | ★☆☆☆☆ |
| beta-Amyrin | 1 supporting sources | ★☆☆☆☆ |
| quercetin | 1 supporting sources | ★☆☆☆☆ |
CATECHIN
- Pharmaceuticals (Basel, Switzerland)
Epicatechin
- Pharmaceuticals (Basel, Switzerland)
Hyperin
- Pharmaceuticals (Basel, Switzerland)
Isoquercetin
- Pharmaceuticals (Basel, Switzerland)
Lupeol
- Pharmaceuticals (Basel, Switzerland)
Procyanidin A1
- Pharmaceuticals (Basel, Switzerland)
Procyanidin B3
- Pharmaceuticals (Basel, Switzerland)
alpha-Amyrin
- Pharmaceuticals (Basel, Switzerland)
beta-Amyrin
- Pharmaceuticals (Basel, Switzerland)
quercetin
- Pharmaceuticals (Basel, Switzerland)
Medicinal Uses
Vaccinium emarginatum has 2 reported medicinal uses identified across 1 scientific publications and several other databases. The most consistently reported uses include Staphylococcus aureus, hepatocellular carcinoma.
Most Reported Uses
| Use | Sources | Consensus |
|---|---|---|
| Staphylococcus aureus | Pharmaceuticals (Basel, Switzerland) (and other 1 sources) | ★☆☆☆☆ |
| hepatocellular carcinoma | Pharmaceuticals (Basel, Switzerland) (and other 1 sources) | ★☆☆☆☆ |
Preparations
| Preparations | Sources | Consensus |
|---|---|---|
| root nodule extract | Pharmaceuticals (Basel, Switzerland) (and other 1 sources) | ★☆☆☆☆ |